# Rare Case of Pulmonary Perivascular Epithelioid Cell Tumor (PEComa) Causing Right Lung Collapse Managed With Bronchial Stenting: A Clinical Challenge

**Authors:** Milan N Regmi, Mohamad N Jajeh, Roger Lin, Kevin Meek, Mina Saba

PMC · DOI: 10.7759/cureus.94753 · Cureus · 2025-10-16

## TL;DR

A rare lung tumor called PEComa caused severe breathing issues in a 62-year-old man and was managed with a bronchial stent.

## Contribution

This case highlights the diagnostic and treatment challenges of pulmonary PEComa and the use of bronchial stenting for palliation.

## Key findings

- Pulmonary PEComa is rare and difficult to diagnose without histopathology.
- Bronchial stenting can be a viable palliative treatment for advanced cases.
- The unpredictable behavior of PEComa necessitates individualized, multidisciplinary care.

## Abstract

Pulmonary perivascular epithelioid cell tumor (PEComa) is an extremely uncommon mesenchymal tumor; pulmonary PEComas can present serious difficulties for both diagnosis and treatment. We present the case of a 62-year-old male with a history of unresectable PEComa of the upper back with metastatic progression to the lungs. Despite ongoing sirolimus therapy, the patient experienced significant tumor growth, presenting to the emergency department with respiratory distress, and was found to have a rapidly enlarging pulmonary mass, later referred for bronchial stenting for palliative treatment. Due to the rarity of these tumors, diagnosis often requires a high index of suspicion and relies on histopathologic confirmation, including immunohistochemistry for melanocytic and muscle markers. Imaging alone is insufficient to distinguish PEComas from other pulmonary masses, underscoring the need for tissue diagnosis. Furthermore, the clinical behaviour of pulmonary PEComas is unpredictable; some remain indolent, while others exhibit aggressive metastatic potential. This heterogeneity complicates treatment planning and highlights the need for individualized, multidisciplinary approaches. We highlight the fact that pulmonary PEComa can rapidly progress and can cause significant morbidity. Palliation with bronchial stenting can be a reasonable option.

## Linked entities

- **Chemicals:** sirolimus (PubChem CID 5284616)
- **Diseases:** PEComa (MONDO:0006359)

## Full-text entities

- **Diseases:** mesenchymal tumor (MESH:C535700), pulmonary mass (MESH:C536030), respiratory distress (MESH:D012128), tumor (MESH:D009369), PEComa (MESH:D054973)
- **Chemicals:** sirolimus (MESH:D020123)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12619690/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12619690/full.md

## References

7 references — full list in the complete paper: https://tomesphere.com/paper/PMC12619690/full.md

---
Source: https://tomesphere.com/paper/PMC12619690